Medifast Inc Stock Buy Hold or Sell Recommendation
| MED Stock | USD 33.42 0.82 2.52% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding MEDIFAST INC is 'Hold'. Macroaxis provides MEDIFAST INC buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MED positions. The advice algorithm takes into account all of MEDIFAST INC's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting MEDIFAST INC's buy or sell advice are summarized below:
Real Value 43.98 | Target Price 81 | Hype Value 32.76 | Market Value 33.42 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell MEDIFAST INC given historical horizon and risk tolerance towards MEDIFAST INC. When Macroaxis issues a 'buy' or 'sell' recommendation for MEDIFAST INC, the advice is generated through an automated system that utilizes algorithms and statistical models.
MEDIFAST |
Execute MEDIFAST INC Buy or Sell Advice
The MEDIFAST recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MEDIFAST INC. Macroaxis does not own or have any residual interests in MEDIFAST INC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MEDIFAST INC's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
MEDIFAST INC Trading Alerts and Improvement Suggestions
| MEDIFAST INC generated a negative expected return over the last 90 days | |
| MEDIFAST INC has high historical volatility and very poor performance | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Q4 Earnings Highlights Este Lauder Vs The Rest Of The Personal Care Stocks |
MEDIFAST INC Returns Distribution Density
The distribution of MEDIFAST INC's historical returns is an attempt to chart the uncertainty of MEDIFAST INC's future price movements. The chart of the probability distribution of MEDIFAST INC daily returns describes the distribution of returns around its average expected value. We use MEDIFAST INC price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MEDIFAST INC returns is essential to provide solid investment advice for MEDIFAST INC.
| Mean Return | -0.65 | Value At Risk | -5.79 | Potential Upside | 4.12 | Standard Deviation | 3.40 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MEDIFAST INC historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MEDIFAST Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as MEDIFAST INC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEDIFAST INC backward and forwards among themselves. MEDIFAST INC's institutional investor refers to the entity that pools money to purchase MEDIFAST INC's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of New York Mellon Corp | 2023-12-31 | 201.1 K | Charles Schwab Investment Management Inc | 2023-12-31 | 186.2 K | Hotchkis & Wiley Capital Management Llc | 2023-12-31 | 167.3 K | American Century Companies Inc | 2023-12-31 | 139.9 K | Jacobs Levy Equity Management, Inc. | 2023-09-30 | 129.7 K | Northern Trust Corp | 2023-12-31 | 125.5 K | Aqr Capital Management Llc | 2023-12-31 | 110.4 K | Ubs Group Ag | 2023-12-31 | 92 K | Ameriprise Financial Inc | 2023-12-31 | 91.3 K | Blackrock Inc | 2023-12-31 | 1.8 M | Vanguard Group Inc | 2023-12-31 | 1.7 M |
MEDIFAST INC Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (9.9M) | (4.6M) | (126.7M) | 61.2M | 64.3M | 67.5M | |
| Change In Cash | (4.4M) | 86.7M | (59.5M) | (16.5M) | 6.7M | 3.8M | |
| Free Cash Flow | 74.2M | 139.3M | 60.3M | 177.9M | 141.2M | 148.2M | |
| Depreciation | 4.6M | 7.3M | 6.8M | 11.0M | 13.1M | 13.8M | |
| Other Non Cash Items | 4.1M | 1.1M | 5.2M | 8.2M | 5.5M | 5.7M | |
| Capital Expenditures | 10.1M | 5.9M | 34.2M | 16.7M | 6.5M | 7.2M | |
| Net Income | 77.9M | 102.9M | 164.0M | 143.6M | 99.4M | 104.4M | |
| End Period Cash Flow | 77.0M | 163.7M | 104.2M | 87.7M | 94.4M | 99.2M | |
| Dividends Paid | 35.4M | 53.2M | 63.9M | 71.6M | 73.0M | 76.7M | |
| Change To Netincome | 9.8M | 8.2M | 6.2M | 12.3M | 14.1M | 14.8M | |
| Investments | 3.7M | 4.6M | 5.1M | 5.3M | (59.4M) | (56.4M) | |
| Change Receivables | 815K | 122K | (4.1M) | 297K | 267.3K | 280.7K |
MEDIFAST INC Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MEDIFAST INC or Personal Care Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MEDIFAST INC's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MEDIFAST stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.77 | |
β | Beta against NYSE Composite | 1.48 | |
σ | Overall volatility | 3.46 | |
Ir | Information ratio | -0.22 |
MEDIFAST INC Volatility Alert
MEDIFAST INC exhibits very low volatility with skewness of -1.78 and kurtosis of 8.14. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MEDIFAST INC's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MEDIFAST INC's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MEDIFAST INC Fundamentals Vs Peers
Comparing MEDIFAST INC's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MEDIFAST INC's direct or indirect competition across all of the common fundamentals between MEDIFAST INC and the related equities. This way, we can detect undervalued stocks with similar characteristics as MEDIFAST INC or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MEDIFAST INC's fundamental indicators could also be used in its relative valuation, which is a method of valuing MEDIFAST INC by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MEDIFAST INC to competition |
| Fundamentals | MEDIFAST INC | Peer Average |
| Return On Equity | 0.56 | -0.31 |
| Return On Asset | 0.25 | -0.14 |
| Profit Margin | 0.09 % | (1.27) % |
| Operating Margin | 0.05 % | (5.51) % |
| Current Valuation | 221.73 M | 16.62 B |
| Shares Outstanding | 10.9 M | 571.82 M |
| Shares Owned By Insiders | 2.70 % | 10.09 % |
| Shares Owned By Institutions | 97.73 % | 39.21 % |
| Number Of Shares Shorted | 2.66 M | 4.71 M |
| Price To Earning | 13.99 X | 28.72 X |
| Price To Book | 1.70 X | 9.51 X |
| Price To Sales | 0.32 X | 11.42 X |
| Revenue | 1.07 B | 9.43 B |
| Gross Profit | 1.14 B | 27.38 B |
| EBITDA | 139.51 M | 3.9 B |
| Net Income | 99.42 M | 570.98 M |
| Cash And Equivalents | 87.69 M | 2.7 B |
| Cash Per Share | 5.57 X | 5.01 X |
| Total Debt | 22.01 M | 5.32 B |
| Debt To Equity | 0.43 % | 48.70 % |
| Current Ratio | 1.29 X | 2.16 X |
| Book Value Per Share | 18.69 X | 1.93 K |
| Cash Flow From Operations | 147.66 M | 971.22 M |
| Short Ratio | 5.83 X | 4.00 X |
| Earnings Per Share | 9.10 X | 3.12 X |
| Price To Earnings To Growth | 1.95 X | 4.89 X |
| Target Price | 37.5 | |
| Number Of Employees | 634 | 18.84 K |
| Beta | 1.15 | -0.15 |
| Market Capitalization | 355.2 M | 19.03 B |
| Total Asset | 309.91 M | 29.47 B |
| Retained Earnings | 174.65 M | 9.33 B |
| Working Capital | 131.73 M | 1.48 B |
Note: Acquisition by Constance Hallquist of tradable shares of MEDIFAST INC at 106.93 subject to Rule 16b-3 [view details]
MEDIFAST INC Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MEDIFAST . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 11501.93 | |||
| Daily Balance Of Power | 0.6119 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 32.96 | |||
| Day Typical Price | 33.11 | |||
| Price Action Indicator | 0.87 | |||
| Period Momentum Indicator | 0.82 |
About MEDIFAST INC Buy or Sell Advice
When is the right time to buy or sell MEDIFAST INC? Buying financial instruments such as MEDIFAST Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 32.5M | 26.1M | 22.0M | 23.1M | Total Assets | 398.3M | 316.2M | 309.9M | 325.4M |
Use Investing Ideas to Build Portfolios
In addition to having MEDIFAST INC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small & Mid Caps ETFs Thematic Idea Now
Small & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small & Mid Caps ETFs theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MEDIFAST INC Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.